Effect of Vascepa on Progression of Coronary Atherosclerosis in Persons With Elevated Triglycerides (200-499) on Statin Therapy
Phase of Trial: Phase IV
Latest Information Update: 29 Jun 2017
At a glance
- Drugs Ethyl eicosapentaenoic acid (Primary)
- Indications Hypertriglyceridaemia
- Focus Therapeutic Use
- Acronyms EVAPORATE
- 29 Jun 2017 Last checked against ClinicalTrials.gov record.
- 23 Jun 2017 Planned End Date changed from 1 Sep 2018 to 1 Sep 2019.
- 10 Jun 2017 Biomarkers information updated